Objective-To determine whether anal intercourse is a risk factor for anal HPV infection in women.
Introduction
When male or female patients present with anal warts, their medical practitioners usually assume that these lesions were acquired as a result of receptive anal intercourse. This situation has arisen because anal warts were considered more common than penile warts in homosexual men,' and most published reports on anal HPV infection have resulted from surveys carried out on this condition in homosexual populations.'> However, several studies have indicated that anal warts are more common than generally perceived in heterosexual men and women: a survey by Oriel7 showed that 18% of women attending a STD clinic had anal warts; others by Goorney et alt and Evans and Fisk9 showed that 30% and 9% respectively of heterosexual men attending STD clinics had anal or perianal warts. In a recent study which we carried out on anal HPV infection in a group of homosexual men, no relationship was detected between the practice of receptive anal intercourse and either clinical or sub-clinical anal HPV infection.6 However, the validity of this observation required further investigation because those who admitted to receptive anal intercourse were over-represented (104 of the 112 subjects, 93%). We therefore decided to study anal HPV infection in a different group ofpatients, where it was suspected that the practice of receptive anal intercourse would not be as prevalent.
The aim of this study was Clinical examination and specimen collection A thorough history regarding past STD infections and sexual history (particularly the practice of receptive anal intercourse) was elicited by direct interview at the first and subsequent visits. A significant number of women (24 out of the original 55 who were investigated) failed to provide information or provided inconsistent information concerning anal intercourse and were later excluded from the study. A complete gynaecological examination was performed by an experienced clinician (CL), at which time specimens for laboratory investigations were collected. The vulva and perineum were carefully inspected prior to the insertion of a disposable speculum for an internal examination of the vagina and cervix. The presence of condyomata or other visible abnormalities was recorded. Cervical scrapes for cytology (Papanicolaou smear) and HPV DNA hybridisation were obtained with modified Ayre's spatulae -the scrape for cytology was always collected prior to that for HPV DNA.
Anal examination consisted of a thorough inspection of the perianal skin with the patient in lithotomy position and the buttocks parted. This was followed by anoscopy using plastic disposable anoscopes with a Heine light source. The presence of external/ internal anal condylomata or any other abnormalities was noted. Cells from the squamo-columnar junction at the dentate line were obtained for cytology and HPV DNA hybridisation with the rounded edge of wooden tongue depressors which had been split in half.
When macroscopic lesions were detected in any of the ano-genital sites, biopsies were taken with the patient's consent under local anaesthesia (2% lignocaine HCl with 1:80 000 adrenaline) administered in a dental syringe with a 30 gauge needle. External condylomata were lifted with 25 gauge needles and then excised with curved iris scissors. Internal lesions were biopsied with Mini-Townsend (Baby Tischler) forceps. Biopsies (1-2 mm) for DNA hybridisation were immediately placed into collection buffer (10 mM Tris-HCl, 1 mM EDTA, 0-1% sodium azide, pH 7.5). The cervical and anal scrapes for cytology were smeared onto a glass slide and immediately fixed using Cytofix spray fixative. For HPV DNA hybridisations the.spatulae were broken off into tubes containing 1 ml collection buffer, then stored at 4°C for a maximum of 48 hours prior to processing.
Cytology
The smears were stained by the routine progressive Papanicolaou stain,'0 screened by a technologist, and then reviewed and reported by a cytopathologist. The presence ofendocervical cells and columnar cells were used as indicators of adequate sampling of the cervical and anal mucosa respectively.`The smears were assessed for evidence of HPV infection or features of CIN or AIN (cervical or anal intraepithelial neoplasia) according to well-accepted criteria" and these were considered "positive". HPV infection was diagnosed on the basis of koilocytosis; or on the presence of at least three of the following features: binucleation, nuclear atypia, parakeratosis, hyperkeratosis, orangeophilia, amphophilia. Smears where no HPV-associated abnormalities were detected, those with inflammatory changes only, and those with only one or two of the cytological features mentioned were considered "negative".
HPV DNA studies These were carried out as previously described.'5 Briefly, washed cell pellets from the scrape specimens were simultaneously lysed and denaturated with 0.5 M NaOH at 95°C for 10 min. The lysates were then transferred to duplicate nylon membranes (GeneScreen Plus, NEN DuPont) using a BiodotTM apparatus (Biorad). Negative (10 ,g foetal nucleic acids and 200 ng pBR 322 DNA) and positive (125 pg-0-125 pg HPV DNA standards) controls were included in each run. For biopsy specimens, approximately 50 mg tissue was finely minced and digested overnight in 600 p1 lysis buffer containing 0. 5 % SDS and 100 pg/ml Proteinase K. The nucleic acids from deproteinised digests were precipitated using ethanol/sodium acetate, then re-hydrated in 50 p1 Tris-EDTA buffer pH 8.0. 5-10 pg total extracted nucleic acids and 200 pg HPV DNA standards were digested with Bam Hl (Pharmacia) then electrophoresed through a 0.7% agarose (Seakem) gel. Nucleic acid fragments were transferred to duplicate Genescreen Plus membranes by the alkaline transfer modification of the method of Southern.
Hybridisation was carried out under high stringency conditions as previously described.'5 Briefly, following prehybridisation for 2 hours, the membranes were incubated overnight at 650C in hybridisation solution containing 2-3 x 106 cpm/pg denatured probe DNA (purified HPV 6/11 or 16/18 DNA labelled with 32P-dCTP: each mixed probe was used for one of the duplicate set of membranes). The membranes were washed 3 x 15 min in 2 x SSC/ 0-1% SDS, and 3 x 15 min in 0.2 x SSC/0.1% SDS at 65°C, then autoradiographed for 3-5 days at -700C. women (47%). In comparison, nine women (56%) from the latter group had vulval/vaginal warts; and a total of 8 (50%) had apparent cervical HPV infection-three (23%) with cytological and molecular indications of HPV in their cervical scrapes, and a further five (31 %) with cervical HPV DNA detected. As shown in table 2, high stringency HPV DNA hybridisation on the anal wart biopsies revealed the presence of HPV 6/11 only in 58%, HPV 16/18 only in 8%; and HPV 6/11 together with HPV 16/18 in 34% of the lesions; while hybridisation on the 15 HPV DNA-positive anal scrapes showed 33% were infected with HPV 6/11 only, 33% had HPV 16/18 only and a further 33% had both 6/11 and 16/18 present. In the genital tract, typing of the 15 HPV DNA-positive cervical scrapes showed that 20% were infected with HPV 6/11 only, 53% with 16/18 only, and 27% with both HPV 6/11 and HPV 16/18.
The results for the 13 women with vaginal or vulval warts showed that the distribution of HPV types in these lesions was not dissimilar to that seen in the anal warts (table 2) . There were no differences in the typing patterns of the lesions from women with or without histories of anal intercourse, nor between lesions situated externally or internally.
Discussion
Anal HPV infection has acquired greater significance in the light of research which has shown that some of the causative papillomaviruses are frequently associated with both premalignant and malignant changes in the anal canal.'6 Of the 20 or more types of HPV which can infect the anogenital tract, HPV types 16 and 18 are frequently detected in tissues which have undergone transformation, whereas HPV types 6 and 11 are most often detected in benign warty lesions.'718 Most published surveys of anal HPV infection have centred on homosexual men, in whom very high rates of HPV infection, both overt and subclinical, have been demonstrated.2' However, it could be argued that this bias is unjustified, since it has been demonstrated that the rate of anal cancer-although highest in homosexual males-is in fact higher in women than in men overall.'9 There is undoubtedly a need to elucidate the nature and epidemiology ofanal HPV infection in both sexes, and to identify possible factors which not only contribute to its transmission, but also to the potential progression of simple infection to premalignancy or invasive cancer.
The finding that 48% of the women surveyed had engaged in anal intercourse at least once was unexpected in view of other reports which have reported the prevalence of anal intercourse as 15-20% in women attending STD clinics in the UK.202' and 25% in women attending for gynaecological services in the USA.22 This figure, which is approximately double that cited by others, is primarily due to the inclusion of those who had experienced anal intercourse only once and to a lesser degree by the inclusion of a small number of prostitute clients. It would have been interesting to stratify the analysis into those who had anal intercourse only once and those who had regular anal intercourse to investigate the likelihood of a "doseresponse" relationship between the practice of anal intercourse and the detection of anal warts but our numbers were too small to allow for this.
The survey described in this report attempted to investigate further the hitherto widely accepted theory that anal intercourse is largely responsible for the spread of anal HPV infection. The rate of clinical or sub-clinical anal HPV infection in the group of women we examined was very high (19/31, 61%), and was similar to that previously found in our study of homosexual men (73/112, 65%),6 despite the difference in the percentages ofpatients who practised receptive anal intercourse in the two groups (48% versus 93%, respectively). Surprisingly, there was no statistically significant correlation between the practice of anal intercourse and the presence of detectable anal HPV infection in the group ofwomen we examined, nor between the site of overt anal HPV infection (that is, site of warts either internal or external to the anal canal) and anal intercourse. Conversely, there was no clear association between anal HPV infection and HPV infection in the genital tract of the women. Interestingly, the rate of dysplastic change in the anal canal was lower in this group of women than in the homosexual men (4% versus 19%);6 and no dysplastic changes greater than AIN I were seen in the females' anal smears, whereas 6% of the males' smears showed more severe dysplastic changes (AIN II).6 This may possibly be a reflection of the higher frequency of anal intercourse with multiple partners, chronic trauma from use of pleasuring devices or enemas, co-existent inflamma-tion due to anal herpes simplex or non-specific proctitis,3 or levels of immunosuppression due to HIV infection245 in homosexual men.
The high rate of both current and past HPV infection in the women surveyed was partially due to the selection bias inherent in a study of women attending an HPV clinic, and obviously indicates that the group is not representative of the general female population. Although some caution must be adopted in applying the conclusions resulting from this survey, the data which have emerged clearly do not support the notion that anal intercourse is the major factor responsible for the development of anal HPV infection. The proximity of the female genitalia and anus could readily permit extension of infection from one region to the other without any requirement for anal sexual contact with an infectious partner. In both men and women other factors-such as coexistent ano-genital STDs or other inflammatory conditions, and disturbances of general or local immunity24-may be more important for the development of anal condylomata than any one particular type of sexual practice.
